(−)-Isoproterenol (+)-bitartrate salt
SIGMA/I2760 - powder
Synonym: (−)-Isoprenaline (+)-bitartrate salt
CAS Number: 54750-10-6
Empirical Formula (Hill Notation): C11H17NO3 · C4H6O6
Molecular Weight: 361.34
MDL Number: MFCD00069361
Linear Formula: C11H17NO3 · C4H6O6
Product Type: Chemical
| color | white to off-white |
| form | powder |
| InChI | 1S/C11H17NO3.C4H6O6/c1-7( |
| InChI key | LBOPECYONBDFEM-RWALOXMOSA |
| originator | Sanofi Aventis |
| Quality Level | 200 ![]() |
| SMILES string | O[C@@H]([C@H](O)C(O)=O)C( |
| solubility | H2O: ≥50 mg/mL, clear, colorless to faintly yellow |
| Application: | (−)-Isoproterenol (+)-bitartrate salt has been used: • as a component in KRH medium for cyclic adenosine monophosphate (cAMP) assay • to stimulate preadipocytes to study its concentration responsive curve • to intraperitoneally administer to mice to evaluate whether the multi-dry-electrode plate (MDEP)-sensor system can assess drug responses |
| Biochem/physiol Actions: | β-Adrenoceptor agonist; increases cytosolic cAMP. |
| Biochem/physiol Actions: | Isoproterenol functions as an ovine pulmonary vein dilator. |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1 g in ampule |
| Packaging: | 100, 500 mg in ampule |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| UNSPSC | 51111800 |


